Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Disch

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Pageof 1